Vivus attracts strong takeover interest

Add to My Stories Print page Add to Favourites

Vivus is understood to have attracted takeover attention from larger rivals including AstraZeneca, GlaxoSmithKline (GSK), Pfizer, Merck and perhaps also Shire. AstraZeneca and Johnson & Johnson are confidently understood to be examining…